Last reviewed · How we verify
NCT05380908
Brain Metabolic Network of PET in Patients With Advanced Non-Small Cell Lung Cancer
trial testing None of any intervention in Advanced Non-small-cell Lung Cancer in 90 participants. Completed in 28 February 2021.
28 February 2021
Quick facts
| Lead sponsor | Fifth Affiliated Hospital, Sun Yat-Sen University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 90 |
| Start date | 1 June 2017 |
| Primary completion | 28 February 2021 |
| Estimated completion | 28 February 2021 |
| Sites | 1 location across China |
Drugs / interventions tested
- None of any intervention
Conditions studied
- Advanced Non-small-cell Lung Cancer — all drugs for Advanced Non-small-cell Lung Cancer →
Sponsor
Fifth Affiliated Hospital, Sun Yat-Sen University
Who can join
Eligibility, any sex, with Advanced Non-small-cell Lung Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a retrospective study, screening patients with systemic PET / CT scan in our department, enrolling the ones who meet the criteria, collect their information and resting state brain PET images.Then make the brain metabolic network analysis and statistical analysis to explore the PET brain metabolic network of non-small cell lung cancer patients and the effect of chemotherapy drugs on brain metabolic network in patients with advanced lung cancer.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05380908
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Advanced Non-small-cell Lung Cancer
Currently open trials in the same condition.
- NCT05904379 — AK112 and AK104 With or Without Chemotherapy in Advanced Non-small Cell Lung Cancer · Phase 1, PHASE2 · active not recruiting
- NCT05499390 — AK112 in Advanced Non-Small Cell Lung Cancer · Phase 3 · active not recruiting
Other Fifth Affiliated Hospital, Sun Yat-Sen University trials
Trials by the same sponsor.
- NCT06079931 — The Efficacy of Babaodan Capsules in Preventing Radiation Pneumonia · Phase 2 · unknown
- NCT06525025 — Building a Traditional Chinese Medicine Clinical Diagnosis and Treatment Database · not yet recruiting
- NCT06060782 — Thiotepa, Cyclophosphamide, Clarithromycin and Cytarabine · Phase 1 · recruiting
- NCT06220552 — The Efficacy and Safety of Low-dose Radiotherapy Combined With Sintilimab and Temozolomide in Recurrent Glioblastoma · Phase 2 · recruiting
- NCT06147947 — Liver and Spleen Stiffness Measured by TE and 2D-SWE for Diagnosis of CSPH in Patients With cACLD · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05380908 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fifth Affiliated Hospital, Sun Yat-Sen University
- Last refreshed: 19 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05380908.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing